178 related articles for article (PubMed ID: 20534161)
1. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients.
Tanni SE; Pelegrino NR; Angeleli AY; Correa C; Godoy I
J Inflamm (Lond); 2010 Jun; 7():29. PubMed ID: 20534161
[TBL] [Abstract][Full Text] [Related]
2. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation in COPD in relation to smoking status.
Serapinas D; Narbekovas A; Juskevicius J; Sakalauskas R
Multidiscip Respir Med; 2011 Aug; 6(4):214-9. PubMed ID: 22958407
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
[TBL] [Abstract][Full Text] [Related]
5. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
[TBL] [Abstract][Full Text] [Related]
6. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
10. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers.
Wozniak K; Sleszycka J; Safianowska A; Wiechno W; Domagala-Kulawik J
Arch Med Sci; 2012 Jul; 8(3):477-83. PubMed ID: 22852003
[TBL] [Abstract][Full Text] [Related]
12. [Systemic inflammatory profile of smokers with and without COPD].
Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
[TBL] [Abstract][Full Text] [Related]
13. Determinants of BMI in patients with COPD.
Karadag F; Karul AB; Cildag O; Altun C; Gurgey O
Respirology; 2004 Mar; 9(1):70-5. PubMed ID: 14982605
[TBL] [Abstract][Full Text] [Related]
14. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
[TBL] [Abstract][Full Text] [Related]
15. [C-Reactive protein levels in patients with chronic obstructive pulmonary disease].
Díaz O; Parada A; Ramos C; Klaassen J; Díaz JC; Andresen M; Lisboa C; Saldías F
Rev Med Chil; 2012 May; 140(5):569-78. PubMed ID: 23096661
[TBL] [Abstract][Full Text] [Related]
16. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
17. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
19. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.
Santini G; Mores N; Shohreh R; Valente S; Dabrowska M; Trové A; Zini G; Cattani P; Fuso L; Mautone A; Mondino C; Pagliari G; Sala A; Folco G; Aiello M; Pisi R; Chetta A; Losi M; Clini E; Ciabattoni G; Montuschi P
J Breath Res; 2016 Jan; 10(1):017102. PubMed ID: 26814886
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha as a marker of systemic and local inflammation in "healthy" smokers.
Diez-Pina JM; Fernandez-Aceñero MJ; Llorente-Alonso MJ; Diaz-Lobato S; Mayoralas S; Florez A
Int J Gen Med; 2009 Jul; 2():9-14. PubMed ID: 20360881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
